Quantcast

Latest Transplantation medicine Stories

2014-09-19 23:04:27

GIA announces the release of a comprehensive global report on Organ and Tissue Transplantation markets. The number of organ transplantation procedures globally is projected to reach about 148 thousand by 2020, driven by aging population, growing number of terminally ill patients, rise in organ donor awareness, and improving patient confidence in transplant procedures supported by better patient outcomes. San Jose, California (PRWEB) September 19, 2014 Follow us on LinkedIn – Buoyed by...

2014-09-03 23:08:03

The New Jersey plastic surgeon establishes the importance of Puregraft technology. Highland Park, NJ (PRWEB) September 03, 2014 Dr. Mark Glasgold is pleased to announce his recently authored study, evaluating the use of Puregraft autologous fat grafting systems. The peer-reviewed paper was published in the July 2014 edition of Aesthetic Surgery Journal. Notable co-authors of the report include Dr. David J. Gerth, Dr. Bethany King, Dr. Lesley Rabach, and Dr. Robert A. Glasgold. The...

2014-09-03 04:21:54

AMSTERDAM, September 3, 2014 /PRNewswire/ -- ~ Clinical and Business Development expert re-joins the Company ~ Kiadis Pharma B.V. ("Kiadis Pharma", "Kiadis" or "the Company"), a clinical stage biopharmaceutical company developing T-cell immunotherapy treatments for blood cancers, today announces the appointment of Dr. Jeroen Rovers, MD PhD, as its Chief Medical Officer. Jeroen Rovers was most recently Chief Medical Officer at Ceronco Biosciences. Prior...

2014-08-28 12:29:36

MILWAUKEE, Aug. 28, 2014 /PRNewswire-USNewswire/ -- BloodCenter of Wisconsin's Diagnostic Laboratories today announced the availability of an innovative Erythroid Chimerism test to monitor erythroid lineage chimerism in patients with sickle cell disease (SCD) following allogeneic bone marrow transplantation. This allows the physician to directly gauge the success of the transplant in these patients and provides physicians with actionable information to guide patient care. Sickle cell...

2014-08-22 23:06:02

MarketOptimizer.org adds “OpportunityAnalyzer Graft-Versus-Host Disease – Opportunity Analysis and Forecasts to 2018” to its store. The GVHD market was valued at $297.0m across the 6MM in 2013, and is expected to increase to $409.0m in 2018. Dallas, Texas (PRWEB) August 22, 2014 The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%. The company’s latest report...

2014-08-20 16:25:44

CENTENNIAL, Colo., Aug. 20, 2014 /PRNewswire-USNewswire/ -- AlloSource, one of the nation's largest providers of skin, bone and soft tissue allografts for use in surgical procedures, and the world's largest processor of cellular bone allografts, today announced the appointment of Milo Metcalf as Vice President of Operations. Metcalf has more than 16 years of experience in engineering and operations roles in the global medical device industry. His background includes oversight of...

2014-08-13 08:29:18

CARLSBAD, Calif., Aug. 13, 2014 /PRNewswire/ -- Advanced Biologics announced today the acceptance for publication of a new OsteoAMP study to be published in the Journal of Spine. In the study titled, Clinical Validation of Allogeneic Morphogenetic Protein: Donor Intervariability, Terminal Irradiation and Age of Product is not Clinically Relevant, an analysis was completed looking at the effects of different variables between allograft donors that were used to process OsteoAMP which...

2014-07-31 12:08:01

Dana-Farber Cancer Institute Study in NEJM reviews 10 years of data, argues for expansion of newborn screening Children born with so-called "bubble boy" disease have the best chance of survival if they undergo a hematopoietic stem cell transplant as soon after birth as possible, according to a detailed analysis of 10 years of outcome data by researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center. These findings, the researchers say, argue for expanding newborn...

2014-07-28 13:28:02

University of Oxford Oxford University scientists have shown that a powerful drug given at the time of a kidney transplant operation not only halves the early risk of rejection, but that it also allows a less toxic regimen of anti-rejection drugs to be used after the operation. The key results are reported in The Lancet and presented at the World Transplant Congress in San Francisco today. They will help doctors faced with a difficult transplant conundrum: the powerful combinations of...

2014-07-28 12:27:34

TOTOWA, N.J., July 28, 2014 /PRNewswire/ -- BiologicTx(®) announced their Discovery 2 Life((TM)) (D2L((TM))), a leading digital health platform designed to guide and support hospitals, clinicians and patients throughout the organ transplant continuum. D2L supports aspects of the organ transplant process, including organization of data associated with enrolling a transplant candidate into a desensitization therapeutic program, donor data management (including identifying optimal...


Latest Transplantation medicine Reference Libraries

Bone Marrow Transplantation (journal)
2012-06-04 20:00:41

Bone Marrow Transplantation is a peer-reviewed medical journal published monthly by Nature Publishing Group. As of May 2012, the editor-in-chief is J.M. Goldman (UK). The journal publishes high quality, original research that addresses all aspects of basic biology and clinical use of haemopoietic stem cell transplantation in humans. The broad scope of the journal thus encompasses topics such as stem cell biology, kinetics and cytokine control, transplantation immunology, HLA and matching...

More Articles (1 articles) »
Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related